“Universal” Flu Vaccine

“Universal” Flu Vaccine

Our Universal Flu Vaccine is based on VLPs assembled with Remodeled HA proteins displaying highly conserved subdominant epitopes able to elicit Broadly Neutralizing Antibody responses in Humans.

Advantages

  • Cross Protection against multiple influenza strains.
  • Reduced frequency of immunization (longer protection).
  • Improved production Planning (manufacturing, storage and distribution).
  • Preliminary pre-clinical studies show that some of our VLP constructs induced antibodies in animal models able of neutralizing the homologous and heterologous virus strains.